SynCraft web server integrates retrosynthesis and ADMET evaluation for streamlined drug design
Abstract. The efficient design of drug candidates requires simultaneous consideration of synthetic feasibility and pharmacokinetic safety. However, current
Read the full articleYou might also wanna read
Why Retrosynthesis Models Are Winning Over LLMs in Drug Discovery
Retrosynthesis models outperform large language models (LLMs) in drug synthesis planning. The URSA framework highlights this gap in precisio
machinebrief.com·6d ago
AI Retrosynthesis Tools: How Machines Plan Chemical Reactions in 2026
Learn how modern AI retrosynthesis tools utilize MCTS and deep learning to plan chemical pathways, and how ChemCopilot integrates them with
ChemCopilot·21d ago
MCP and Pharma: How AI Agents Connect to Drug Discovery, Clinical Trials, Genomics, Chemical Databases, Protein Structure, FDA Regulatory Data, and Life Sciences Platforms
A comprehensive guide to MCP integrations for pharmaceuticals, biotechnology, and life sciences — covering drug discovery tools (RDKit, mole
chatforest.com·3mo ago
AI Advances in Drug Discovery: From Data Integration to Dual-Action Cancer Drug Design
Featured content
drugtargetreview.com·5mo ago
Network-driven discovery of repurposable drugs targeting hallmarks of aging
Network-driven discovery of repurposable drugs targeting hallmarks of aging
nature.com·14d ago
<![CDATA[Molecular Response Monitoring and Treatment Optimization]]>
CancerNetwork·8d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.